MUK nine opens for recruitment

Myeloma UK is pleased to announce that MUK nine is the latest trial in the Myeloma UK Clinical Trial Network (CTN) open to patient recruitment. The aim of MUK nine is to stratify treatment for high-risk myeloma patients. Up to 700 newly diagnosed myeloma patients will be recruited and screened at the Institute of Cancer…

Details